Multi-Therapeutic Bulk Drug Manufacturing

The site produces 12 APIs across multiple therapeutic areas, running over 50 reaction vessels across two dedicated production blocks.
Get in Touch
Small white powder sample in a petri dish with spatula for drug manufacturing displayIndustrial chemical processing facility with multiple reactors and piping systems

Capabilities

Reaction & Synthesis

Two production blocks handle different stages of the manufacturing process - one for finished API synthesis, one for earlier-stage chemistry.
50+ stirred vessels across SS, glass-lined, PP, and FRP materials
Vessel volumes from 100 L bench-scale to 6,300 L
Sparkler filters, filter press, and nanofiltration for liquid processing
Industrial chemical processing equipment including tanks and piping for pharmaceutical manufacturing

Isolation & Drying

A full suite of drying and powder processing equipment supports the range of API chemistries manufactured on-site.
Centrifuges, rotacone vacuum dryers, fluidised bed dryers, and paddle dryer
Multimills, sifters, air classifier mill, and micronizer for powder processing
Industrial chemical processing equipment including tanks and piping for pharmaceutical manufacturing

Water & Utilities

The site runs a fully controlled water generation and distribution system alongside comprehensive utility infrastructure.
PLC-controlled RO system with 4,000 LPH generation
Dedicated solvent recovery plant and on-site effluent treatment
Industrial chemical processing equipment including tanks and piping for pharmaceutical manufacturing

Quality Control

All testing is handled in-house across five dedicated labs.
HPLC, GC with headspace, FTIR, UV-Vis, and polarimetry
Walk-in ICH stability chambers
Six external labs empanelled for specialised testing
Industrial chemical processing equipment including tanks and piping for pharmaceutical manufacturing

Approvals & Certifications

India / WHO scheme
India / WHO scheme
21 CFR Part 210/211 United States
EU & UK
EU & UK
EU & UK
EU & UK
India / WHO scheme
India / WHO scheme
21 CFR Part 210/211 United States
EU & UK
EU & UK
EU & UK
EU & UK